polyphosphate phosphatases, and sphingomyelinases (12) . The similarity of CdtB to DNase I, in particular, has attracted attention and led to the demonstration of in vitro DNase activity by CDT, but not by CDT containing CdtB subunits mutated in residues predicted to be critical for catalysis based on the DNase I mechanism (17) . Furthermore, ectopic expression in mammalian cells of the CdtB subunit alone, but not the CdtA or CdtC subunits, recapitulates the toxic effects obtained when cells are treated with CDT (28) . These results readily explain the CDT-induced G 2 cell cycle arrest that has been noted in multiple studies (6, 8, 35, 42, 44, 46, 50) as resulting from elicitation of the cell's DNA damage checkpoint response. Contrary to this model, however, CDT-induced DNA damage in vivo was specifically rejected as a potential mechanism by Sert et al. (42) and the rather weak in vitro CdtB DNase activity (28) seems inconsistent with the potency of CDT as a toxin. Moreover, the critical residues of CdtB predicted to be important for its putative DNase activity are similarly predicted to be important for any potential phosphoesterase activity based on the similarities noted by Dlakić (12) . Any of these other potential activities could conceivably result in the activation of a G 2 checkpoint response.
In an effort to clarify some of these issues and gain further understanding of how CDT causes disease, we have explored the use of a more tractable model system to study the in vivo mechanism of CDT toxicity. In this study, we show that expression of CdtB-but not CdtA, CdtC, or a CdtB mutant in a residue predicted to be essential for phosphoesterase activity-in the yeast Saccharomyces cerevisiae induces an irreversible G 2 cell cycle arrest accompanied by degradation of the chromosomal DNA.
MATERIALS AND METHODS
Strains, medium, and cell culture methods. Yeast strains used in this study are outlined in Table 1 . S. cerevisiae strains Y300 and Y610 were generous gifts from S. J. Elledge (Baylor University, Houston, Tex.). Y477 and Y510 were generous gifts from D. Lew (Duke University, Durham, N.C.). Where appropriate, yeast was grown in either standard YPD medium or SD medium at 30°C lacking the appropriate amino acid with either 2% glucose, sucrose, or galactose as a carbon source. Broth cultures were shaken at 250 rpm. Semisolid medium contained 1.5% agar (Difco, Detroit, Mich.).
Plasmids. The following plasmids were used: pTrc18CDT containing the wildtype cdtA, cdtB, and cdtC genes isolated from C. jejuni 81-176 (50); and pDCHCdtA, pDCH-CdtB, and pDCH-CdtC, pDCH-CdtB D222A , which are yeast expression plasmids that express cdtA, cdtB, cdtC, and cdtB containing a point mutation changing Asp-222 to an Ala-222, respectively, under the control of the GAL1 promoter. The yeast plasmids in this study are based on the low-copynumber CEN4, LEU2-based yeast expression vector, pMDM00333, which consisted of the GAL1-GAL10 intergenic region of pBM150 (25) cloned into the multiple cloning site of YCplac111 (22) . The cdt genes were cloned as XbaI-SalI fragments into the remaining portion of the multiple cloning site. In all yeast plasmids, cdtA, cdtB, or cdtC genes were truncated and mutagenized so as to lack their putative leader sequences and contain a Kozak consensus start codon (27) , which was confirmed by sequence analysis.
PCR isolation of cdt genes. Using pTrc18CDT as a template, the three CDT subunits were individually PCR amplified with Vent DNA polymerase as per the manufacturer's recommendations (New England Biolabs, Beverly, Mass.) with the following subunit-specific primers (Integrated DNA Technologies, Coralville, Iowa): cdtA was amplified with 5Ј-CGCGTCTAGAACTATGGAAAAT GTAAATCCTTTGGGGCGTTCATTTGC-3Ј and 5Ј-GCGGGTCGACTTTTC ATCGTACCTCTCCTTGGCG-3Ј, cdtB was amplified with 5Ј-CGCGTCTAGA AATATATGGAAAATTTTAATGTTGGCACTTGG-3Ј and 5Ј-GGCGGTCG ACTGTCCTAAAATTTTCTAAAATTTACTGG-3Ј, and cdtC was amplified with 5Ј-GCGCTCTAGAACAATGGGAGATTTGAAAGATTTTACCGAAA T-3Ј and 5Ј-GGCGGTCGACCAAGATAAAAATCTTATTCTAAAGGGGTA GC-3Ј.
Directed mutagenesis of cdtB. Asp-222 was changed to Ala-222 by the ExSite protocol (Stratagene, La Jolla, Calif.) with the mutagenic oligonucleotides 5Ј-C TCTTGCTTATGCAATTACAGGAAATTC-3Ј and 5Ј-TCCCTCCGCTTGCT TGAGTTGCTGC-3Ј against pTrc18CDT template to generate cdtB D222A . Mutants were identified by nucleotide sequence analysis.
Yeast transformation. Yeast strains were transformed with plasmid DNA according to the EasyComp protocol (Invitrogen, San Diego, Calif.).
Induction of gene expression with galactose. GAL1-controlled genes were activated by harvesting exponentially growing cells from media containing sucrose, washing them in galactose-containing media, and then shifting them to galactose. Immediately prior to induction with galactose, cells were harvested by centrifugation and resuspended in the appropriate SD medium containing 2% galactose to a final optical density at 600 nm (OD 600 ) of 0.1 to 0.3.
Measurement of yeast DNA content. Yeast DNA content was measured throughout these experiments by propidium iodide (PI) staining essentially as described previously (39) . At least 10,000 events were assessed for PI fluorescence intensity with a FACScan flow cytometer (Becton-Dickinson, Franklin Lakes, N.J.) in each assay.
Microscopy. Microscopic images were obtained on an AxioPhot microscope (Carl Zeiss, Inc., Thornwood, N.Y.) equipped with a Spot digital camera (Diagnostic Instruments, Sterling Heights, Mich.). Prior to microscopy, cells were sonicated at 45% power for 5 s to separate individual cells. For Nomarski imaging, cells were placed on poly-L-lysine-coated coverslips for 5 min and then mounted onto glass slides. For nuclear visualization, cells were fixed in 70% ethanol for at least 30 min at 4°C and then stained for 5 min in 10 g of Hoechst 33342 per ml (Molecular Probes, Eugene, Oreg.).
RT-PCR of yeast transcripts. Equivalent cell numbers were washed and resuspended in a mixture of 40 mM phosphate buffer (pH 6.8) and 1.2 M sorbitol containing 75 U of lyticase per ml. After 30 min of incubation at 30°C, total RNA was extracted from spheroplasts by using Trizol (Life Technologies, Rockville, Maryland) and submitted to reverse transcriptase PCR (RT-PCR) according to the manufacturer's specifications by using primer sets for either RNR2 or GPD1. Band intensities on agarose gels were quantified by using Kodak 1-D Image Software (Rochester, N.Y.). All RNA preparations were checked for genomic DNA contamination by PCR with equivalent amounts of nonreverse-transcribed RNA preparations as a template for 32 cycles with the GPD1 primer set.
PFGE. Yeast chromosomal DNA was resolved by running contour-clamped homogeneous electric field gels essentially as described previously (21) by using equivalent numbers of yeast cells. Briefly, whole cells were embedded in plugs consisting of 0.7% low-melting-point agarose in the presence of lyticase and 10 mM Tris-HCl (pH 7.5)-0.5 M EDTA for 18 h at 37°C. Plugs were then transferred to a solution containing 1% Sarkosyl, 2 mg of proteinase K per ml, 10 mM Tris-HCl (pH 7.5), and 0.5 M EDTA for 18 to 24 h at 50°C. Afterwards, the agarose plugs were washed and dialyzed against 10 mM Tris-HCl (pH 7.5)-50 mM EDTA (pH 7.5) for 6 h at room temperature. Pulsed-field gel electrophoresis (PFGE) was conducted at 200 V with a 60-s pulse frequency for 20 h. The gel was poststained with ethidium bromide and observed under UV transillumination.
RESULTS
Expression of CdtB unaccompanied by other CDT subunits is toxic in S. cerevisiae. We evaluated whether cdtA, cdtB, or cdtC possesses a toxic activity by ectopically expressing each CDT subunit under the control of the GAL1 promoter in the S. cerevisiae EY957 genetic background (Table 1 ). All strains grew normally on glucose when compared to the vector control strain (Fig. 1A) . However, when expression of the CDT subunits was induced by restreaking colonies onto medium containing galactose, only CdtA, CdtC, and the vector control grew, requiring 2 to 3 days at 30°C to obtain colonies that were clearly visible. In contrast, growth was not detected when yeast expressed CdtB, even when plates were incubated for 5 days. To confirm that the subunits were expressed, we performed Western blots with protein derived from the same yeast strains grown in broth culture in the presence of galactose. Each of these subunit proteins was detected under the inducing conditions (not shown).
Mutations in phosphoesterase-like residues of CdtB result in loss of toxicity. To ascertain whether it was a possible phosphoesterase-like activity that was responsible for the CdtB toxicity in yeast cells, we constructed a series of point mutations in residues of CdtB expected to be critical for its putative catalytic activity (12) . Among these mutants was an aspartate-to-alanine mutation in position 222 of wild-type CdtB (CdtB D222A ). CDT holotoxin in which CdtB was replaced with (Fig. 1A) . The presence of CdtB D222A in yeast growing in galactose-containing medium was confirmed by Western blot analysis (not shown). These results indicated that the toxicity was likely to be due to a specific enzymatic activity of CdtB and not just generally to its expression in a heterologous organism.
CdtB expression is associated with an irreversible loss of viability. Glucose is a potent inhibitor of GAL1-controlled expression (19) . To determine whether CdtB was causing a loss of viability, cells were taken out of galactose-containing liquid medium, washed, and plated onto glucose-containing medium (YPD) at 0, 5, and 7 h postinduction of CdtB. After 7 h of growth in galactose-containing medium, the cultures containing yeast that expressed CdtB produced many fewer colonies (ϳ20% relative to time 0). However, the number of colonies produced from cultures expressing mutant CdtB D222A allele increased (Fig. 1B) , thus establishing that the toxic effects of CdtB were irreversibly lethal and dependent upon a phosphoesterase-like residue.
Expression of CdtB produces a large-budded terminal phenotype accompanied by a G 2 arrest. Changes in cellular morphology often reveal the general nature of cell cycle defects in yeast. For example, accumulations of unbudded cells are largely indicative of a G 1 arrest, while accumulations of largebudded cells suggest an accumulation of G 2 or M-phase cells (29) . We determined whether expression of individual CDT subunits could induce morphological changes in yeast. Exponentially growing yeast cells encoding GAL1-controlled CdtA, CdtB, CdtC, or CdtB D222A were shifted into galactose-containing medium to induce gene expression. Cells were then sampled from growing liquid cultures at 0, 5, 7, and 10 h postinduction. The CdtB-expressing strain predominantly exhibited a marked increase in the size of both the mother cell and bud that was absent with expression of CdtB D222A ( Fig. 2A) . distribution. At 7 h postinduction, we observed CdtB-expressing cells noticeably accumulating in G 2 phase, while CdtB D222A -expressing yeast did not. At 10 h postinduction, this effect was even more prominent. The distribution of DNA content in cells expressing CdtA or CdtC (not shown) was similar to that of vector control cells at 10 h (Fig. 3A) , suggesting that neither CdtA nor CdtC was able to affect cell cycle progression. These findings suggested that cells were arresting primarily at G 2 /M, as was seen previously in mammalian cells intoxicated with CDT (8, 10, 35, 42, 44, 46, 50, 52) , and that this activity could be attributed directly to CdtB in an Asp-222-dependent fashion. This result provided an initial validation of the relevance of our yeast model to CDT-related disease, and we pursued it further.
The nuclear morphology of the arrested cells was examined by Hoechst 33342 staining (Fig. 3B) . As expected for a G 2 /M arrest, the moderately sized cells possessing large buds accumulated with a single nucleus located at the mother-daughter neck. The larger cells, which had presumably sat at the arrest point for an extended period of time, often appeared to have an unequally fragmented nucleus, as if the cells had attempted to segregate chromosomes that were not fully attached to the spindle or that were unable to separate sister chromatids. This phenomenon in which cells bypass a checkpoint after extended arrest and which results in misegregation of chromosomal DNA has been observed previously (40, 48) . similar network of regulators controlling Cdk1 phosphorylation in S. cerevisiae, however, DNA damage does not result in inhibitory Cdk1 phosphorylation. These regulators are instead ultimately responsive to disruptions leading to loss of cell polarity, and the DNA damage cell cycle arrest response is accomplished by alternative means (11, 29, 32, 33, 49) .
We took advantage of this divergence to determine whether CdtB acted on the pathway near Cdk1, possibly as a protein phosphatase, by expressing CdtB in yeast in which wild-type Cdk1 was replaced with the Cdk1-AF allele, which lacks both sites needed for inhibitory phosphorylation. If phosphorylation of Cdk1 were critical for CDT toxicity, this mutant would not become intoxicated when CdtB is expressed. If it acted through the DNA damage pathway, we expected this mutant to remain sensitive to CdtB. We found that expression of CdtB resulted in toxicity when expressed in yeast containing the Cdk1-AF allele as well as a syngenic control strain. This indicated that CdtB did not act upon Cdk1 or upon the proximal regulators in the pathway leading to Cdk1 inhibitory phosphorylation.
mec1 mutants of S. cerevisiae are susceptible to intoxication with CdtB. The Mec1 protein of S. cerevisiae is required for both the S-phase and G 2 checkpoints responsive to DNA damage and unreplicated DNA (49) . Mec1 is a homologue of the mammalian ATM protein, which performs a similar function in mammalian cells (33) . The G 2 /M accumulation of cells associated with CDT intoxication is abolished by caffeine (9, 42) , an ATM inhibitor (4), and results from an ATM-dependent checkpoint (9) . To determine whether the yeast arrest resulted from the activation of the corresponding checkpoint, CdtB was expressed in both a mec1 null strain and its syngenic counterpart. We then analyzed these CdtB-expressing strains as before alongside vector controls. If CdtB were causing physical damage to S. cerevisiae, we expected that the mec1 null yeast would still lose viability after expressing CdtB, but would not arrest at the G 2 checkpoint. Alternatively, if CdtB were merely causing the perception of damage by manipulating the DNA damage sensory machinery at the level of Mec1 or upstream, the CdtBexpressing yeast should survive. All CdtB-expressing strains, including the mec1 strain, failed to grow in galactose-containing media, suggesting physical damage and not manipulation of proteins involved in the checkpoint. Flow cytometric analysis of cellular DNA content indicated that cells continued to arrest with G 2 /M DNA content despite the absence of the G 2 checkpoint (Fig. 3C) . It is possible that the G 2 arrest in the mec1 background is due to the activation of an independent checkpoint, perhaps that involving spindle attachment to the kinetochores-a possibility currently undergoing investigation.
RNR2 upregulation is associated with CdtB expression. In light of the Asp-222-dependent toxicity of CdtB, we revisited the possibility of a CdtB-associated DNA damage response by examining RNR2 transcription. Upregulation of RNR2 occurs when yeast cells are exposed to DNA-damaging agents such as uv radiation or hydrogen peroxide (3, (14) (15) (16) . Specific reporter systems have been described in yeast to identify genotoxins based on this upregulation (1, 2). We used RT-PCR to evaluate RNR2 expression semiquantitatively in yeast expressing either CdtB or CdtB D222A alongside positive and negative controls. CdtB expression resulted in an Asp-222-dependent increase in RNR2 transcription, which was also observed with hydrogen peroxide treatment, but absent in the vector control (Fig. 4) . The RNR2 band is evident as early as 21 cycles of PCR in both CdtB-expressing cells and hydrogen peroxide-treated cells. Transcription of another gene unrelated to the DNA damage checkpoint, GPD1, was similar in both vector control yeast and CdtB D222A -expressing yeast. GPD1 transcription was notably reduced by treatment with hydrogen peroxide and modestly reduced during expression of CdtB-possibly the result of nonspecific toxicity or stress associated with these treatments. The augmented RNR2 transcription suggested that CdtB possesses a genotoxic activity, consistent with its putative role as a DNase.
CdtB, but not CdtB D222A , causes degradation of chromosomal DNA in vivo. These results encouraged us to look at the integrity of yeast chromosomes by using PFGE to ascertain whether potential DNA damage resulting from CdtB expression could be directly observed. Chromosomes isolated from yeast expressing CdtB were compared to chromosomes from yeast expressing CdtA, CdtC, CdtB D222A , or the vector control at 0, 6, or 10 h postinduction. We found that chromosomes from all yeast obtained at time 0 were entirely intact relative to the vector control (Fig. 5) . Initial evidence of CdtB-associated chromosome degradation was apparent by 6 h postinduction (not shown). However, by 10 h postinduction, CdtB-associated degradation was very apparent and consisted of a smear of high-molecular-weight DNA (Fig. 5, lane 7) . CdtB expression was also accompanied by production of a relatively low-molecular-weight RNA fragment (Fig. 5, lane 7 , white arrow) as determined by sensitivity to RNase A, presumably arising from continued biosynthesis in the absence of cell division. We are further characterizing this observation. In contrast, yeast expressing CdtA, CdtC, or CdtB D222A did not undergo detectable damage (Fig. 5, lanes 6 and 8 to 10) . Thus, the degradation was only associated with CdtB and depended absolutely on the DNase-related residue, Asp-222.
DISCUSSION
We have shown here that a yeast model system can be used to analyze the action of the C. jejuni Cdt subunits. The action of CDT on mammalian cells has been shown to cause G 2 arrest, likely due to invoking of the DNA damage-incomplete replication checkpoints. Expression of CdtB alone was sufficient to cause a G 2 block in S. cerevisiae, and use of S. cerevisiae mutants allowed us to clearly show that CdtB does not directly act on cell cycle machinery, but instead appears to involve direct damage and subsequent activation of the checkpoint pathway. In addition to use of the mutants for examining possible invocation of the checkpoint pathway, we showed that activation of RNR2, a gene known to be upregulated in response to direct DNA damage, occurred as early as 4 h after induction of CdtB expression. At 4 h, this observation occurred several hours before loss of chromosomal integrity could be detected by PFGE and before cells accumulated in G 2 /M. There is current evidence supporting this hypothesis: an unspecified amount of purified CdtB demonstrates DNase activity (17) , albeit weak (28), in vitro, and when CdtB is microinjected into mammalian cells, these cells become distended at low doses, while chromatin collapse visualized by nuclear staining is observed at relatively higher doses (28) . The results reported here add further support to the idea that CDT is indeed a nuclease and to the finding that CDT invokes the DNA damage checkpoint reported previously by Cortes-Bratti et al. (9) and Sert et al. (43) . Finally, since yeast have relatively small and separable chromosomes compared to mammalian cells, we were able to use PFGE to analyze whether CdtB caused noticeable DNA damage in our system. This is the first time this type of analysis has been done with CDT-affected cells and provides visual confirmation of the action of CdtB in vivo in a way not previously demonstrated. Thus, this study indicates the likelihood that CdtB does indeed have DNase I-like activity.
However, it must be pointed out that under some circumstances, yeasts appear to undergo an apoptotic-like response (30) . Therefore, it is important to consider the possibility that the DNA degradation we observed might be the downstream result of such a response induced by CdtB. Since the apoptotic response has been a complicating factor in determining the CdtB mechanism in mammalian cells (28), we have attempted to resolve this issue by determining whether the production of reactive oxygen species (ROS) occurs in response to CdtB, an effect that is independent of nuclear events, but common to both the mammalian and yeast apoptotic-like responses. We found that CdtB-associated DNA damage in yeast occurs in the absence of ROS production, suggesting that the yeast apoptotic-like response is not responsible for the DNA damage associated with CdtB expression (Pickett, unpublished) . We are continuing to investigate this possibility further in both our yeast model and in mammalian cells. However, in light of the in vitro DNase activity of CdtB (17), we consider it likely that the chromosome degradation that we are observing in vivo is a direct result of the action of CdtB-demonstrating that CDTs induce cell death as a novel class of bacterial genotoxins.
Our findings contradict a report by Sert et al. (42) in which it was suggested that cells intoxicated with CDT did not undergo DNA damage. Possibly, the extent of DNA damage associated with closer-to-physiological CDT doses is not detectable in the assays used by those authors. In our study, amounts of CdtB per cell (and per unit genome size) are likely to be considerably higher than during intoxication of mammalian cells with the CDT holotoxin. Consequently, the extent of DNA degradation is likely enhanced in our system, making the biological role of CdtB more readily apparent in vivo. This would appear to be another advantage of using this novel yeast model system for the study of a bacterial protein that brings about a cell cycle block apparently through very modest DNA damage. We consider it possible that CdtB preferentially targets a particular DNA site or structure, the damage to which cannot be detected by standard assays at lower doses of CdtB. FIG. 5 . Chromosome degradation is dependent on a DNase-related residue of CdtB. Yeast chromosomes, ranging in size from 220 to 1,600 kb, are resolved by PFGE. Chromosomes isolated at time 0 (lanes 1 to 5) are compared to chromosomes isolated after 10 h of growth in galactose-containing medium (lanes 6 to 10). The CdtAexpressing strain (DCH6041; lanes 1 and 6), CdtB-expressing strain (DCH6042; lanes 2 and 7), CdtC-expressing strain (DCH6043; lanes 3 and 8), CdtB D222A -expressing strain (DCH6044; lanes 4 and 9), and the vector control strain (DCH6045; lanes 5 and 10) are compared. The white arrow indicates the position of an RNA product associated with expression of CdtB.
The ability of CdtB to recapitulate in yeast the major effects observed with CDT-treated mammalian cells (38) suggests that yeast can serve as an excellent model organism that can be exploited to further understand how CDTs cause disease in vivo. Moreover, the CdtB-expressing yeast developed in this work have potential application as a drug screening system in which CDT-inhibiting compounds are identified by selection for yeast that can grow during expression of CdtB.
